Rights holders accused Bristol Myers of failing to submit critical information to the FDA and ready plants or inspection, in a bid to delay the approvals and avoid the $6.4 billion payout, while publicly pledging to use "diligent" efforts to meet the Dec. 2020 and March 2021 deadlines. U.S. District Judge Jesse Furman in Manhattan, however, found no proof of an intent to defraud.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/gpm4ul0
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer drug delay
https://ift.tt/Y5kcrpM
No comments:
Post a Comment